Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1Breast 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 3Lymphoma, Large B-Cell, Diffuse 3Lymphoma, B-Cell 3Neoplasm, Residual 2Lymphoma, Non-Hodgkin 2Lymphoma, Mantle-Cell 2Lymphoma, Follicular 2Leukemia, Lymphocytic, Chronic, B-Cell 2Burkitt Lymphoma 2Stomach Neoplasms 1Recurrence 1Pancreatic Neoplasms 1Ovarian Neoplasms 1Neoplasms 1Mesothelioma, Malignant 1Meningeal Carcinomatosis 1Lymphoma, B-Cell, Marginal Zone 1Lymphoma 1Leukemia, Lymphoid 1Leukemia 1Carcinoma, Ovarian Epithelial 1Breast Neoplasms 1Brain Neoplasms 1

Interventions

Radiotherapy 2toripalimab 1pertuzumab 1lorlatinib 1azeliragon 1adavosertib 1Trastuzumab 1Radiation 1Pemetrexed 1Immunotherapy, Adoptive 1GDC-0084 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Active not recruiting × Meningeal Carcinomatosis × Immunotherapy, Adoptive × Clear all
NCT03696030 2026-04-23

HER2-CAR T Cells in Treating Patients With Recurrent Brain or Leptomeningeal Metastases

City of Hope Medical Center

Phase 1 Active not recruiting
24 enrolled
BreastCNS

Brain Neoplasms, Breast Neoplasms, Neoplasms, Meningeal Carcinomatosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡